Tenet Healthcare Corporation (NYSE:THC) Receives $273.00 Average Target Price from Brokerages

Shares of Tenet Healthcare Corporation (NYSE:THC) have received a consensus rating of “Moderate Buy” from the twenty-one research firms that are presently covering the company, Marketbeat Ratings reports. Two research analysts have rated the stock with a hold rating, eighteen have issued a buy rating and one has given a strong buy rating to the company. The average twelve-month price objective among analysts that have issued ratings on the stock in the last year is $273.00.

Several brokerages recently issued reports on THC. The Goldman Sachs Group restated a “buy” rating and issued a $305.00 target price on shares of Tenet Healthcare in a report on Tuesday, July 28th. Royal Bank Of Canada increased their price target on Tenet Healthcare from $236.00 to $283.00 and gave the company an “outperform” rating in a report on Monday, July 27th. Piper Sandler set a $308.00 price target on Tenet Healthcare in a research note on Monday, July 27th. Robert W. Baird upped their price objective on Tenet Healthcare from $210.00 to $280.00 and gave the company a “neutral” rating in a research report on Tuesday, July 28th. Finally, Morgan Stanley increased their target price on Tenet Healthcare from $254.00 to $274.00 and gave the company an “overweight” rating in a report on Monday, July 27th.

Tenet Healthcare Price Performance

NYSE THC opened at $269.11 on Monday. Tenet Healthcare has a one year low of $157.58 and a one year high of $277.76. The stock has a 50-day moving average of $216.42 and a 200 day moving average of $205.69. The company has a debt-to-equity ratio of 2.00, a quick ratio of 1.35 and a current ratio of 1.41. The company has a market capitalization of $21.67 billion, a price-to-earnings ratio of 10.38, a PEG ratio of 1.03 and a beta of 1.23.

Tenet Healthcare (NYSE:THC) last announced its quarterly earnings results on Thursday, July 23rd. The company reported $6.12 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.26 by $1.86. Tenet Healthcare had a net margin of 10.27% and a return on equity of 26.76%. The firm had revenue of $6.04 billion for the quarter, compared to the consensus estimate of $5.43 billion. During the same quarter last year, the firm posted $4.02 EPS. The business’s quarterly revenue was up 6.8% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. On average, sell-side analysts forecast that Tenet Healthcare will post 20.97 EPS for the current year.

Insider Transactions at Tenet Healthcare

In related news, Director J Robert Kerrey sold 5,638 shares of the firm’s stock in a transaction that occurred on Thursday, May 28th. The shares were sold at an average price of $174.52, for a total value of $983,943.76. Following the transaction, the director owned 16,804 shares of the company’s stock, valued at approximately $2,932,634.08. This trade represents a 25.12% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, EVP Paola M. Arbour sold 10,878 shares of the business’s stock in a transaction that occurred on Monday, July 27th. The shares were sold at an average price of $243.90, for a total transaction of $2,653,144.20. Following the sale, the executive vice president owned 18,413 shares of the company’s stock, valued at $4,490,930.70. This trade represents a 37.14% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last ninety days, insiders have sold 41,375 shares of company stock worth $9,793,347. 0.97% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Tenet Healthcare

Several institutional investors and hedge funds have recently bought and sold shares of the stock. NewEdge Advisors LLC increased its position in Tenet Healthcare by 6.1% in the first quarter. NewEdge Advisors LLC now owns 2,890 shares of the company’s stock worth $389,000 after buying an additional 166 shares in the last quarter. Jones Financial Companies Lllp grew its stake in shares of Tenet Healthcare by 299.1% during the 1st quarter. Jones Financial Companies Lllp now owns 1,700 shares of the company’s stock valued at $229,000 after acquiring an additional 1,274 shares during the period. Sivia Capital Partners LLC purchased a new stake in Tenet Healthcare in the 2nd quarter worth approximately $290,000. Quantbot Technologies LP bought a new stake in Tenet Healthcare during the 2nd quarter worth approximately $65,000. Finally, Amundi lifted its holdings in Tenet Healthcare by 4,207.8% during the second quarter. Amundi now owns 27,010 shares of the company’s stock valued at $4,652,000 after purchasing an additional 26,383 shares in the last quarter. 95.44% of the stock is currently owned by hedge funds and other institutional investors.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.